Scalp and hair exam
The exam is looking for a small number of things. Is the loss patterned or spread evenly? Are hairs shedding whole, or snapping off? Is there redness or loss of the follicular openings, which points toward scarring?
The pull test grasps roughly 50 to 60 hairs and counts what releases. Older references called six or fewer normal, but a 2017 evidence-based revision published in the Journal of the American Academy of Dermatology found that 2 hairs or fewer was normal in 97.2% of participants, and that the old five-day no-washing restriction wasn't necessary. Dermoscopy adds magnification, which shows miniaturized hairs in pattern loss or exclamation-point hairs in active alopecia areata. Biopsy is reserved for cases where scarring is suspected or the picture won't resolve.
Miniaturization is the finding that settles a lot of arguments. On biopsy, the terminal-to-vellus hair ratio in female pattern loss drops from a normal 8:1 to around 2.2:1, and any ratio below 4:1 is diagnostic. That's a structural finding no blood test replaces.
Hormone testing for hair loss
Here's where a lot of money gets spent badly on hormone testing for hair loss. Hormone testing for hair loss should follow the symptoms, not precede them, because a panel ordered without a question attached produces numbers you then have to explain away.
The Endocrine Society's 2018 hirsutism guideline is instructive on restraint. It suggests testing for elevated androgen levels in women with an abnormal hirsutism score, and recommends against testing in eumenorrheic women with unwanted local hair growth, because the likelihood of finding a disorder that changes management is low. Same logic applies to the scalp.
What gets considered depends on what your history turned up:
-
Thyroid function when the shedding is diffuse or other thyroid symptoms are present
-
Ferritin alongside a complete blood count, with C-reactive protein when inflammation distorts the ferritin reading
-
Early morning total and free testosterone when hirsutism or cycle irregularity accompany the hair change
-
17-hydroxyprogesterone when congenital adrenal hyperplasia is a realistic possibility
Hormone testing for hair loss earns its place when a symptom cluster justifies it. Ordered reflexively, hormone testing for hair loss mostly generates borderline results and false reassurance.
Hormone therapy for hair loss
Hormone therapy for hair loss makes sense in two situations, and it's worth being precise about which one you're in. The first is a documented endocrine problem where correcting it is the right move regardless of your hair. The second is when you're already weighing hormone therapy for menopausal symptoms and hair is one factor among several.
What it isn't is a hair treatment. The North American Menopause Society's 2022 position statement says that hair density and female pattern hair loss worsen after menopause, but that research is lacking regarding a role for hormone therapy for hair loss in mitigating those changes, rated at Level II evidence.
A 2026 systematic review in the Journal of the American Academy of Dermatology reached the same conclusion. Shoshana Marmon, assistant professor of dermatology at New York Medical College, told Healio: "Based on the current evidence, we cannot say that estrogen promotes hair growth in menopausal women." She added that the evidence is limited, heterogenous and insufficient to support estrogen as a routine hormone therapy for hair loss, and noted that many topical estrogen studies didn't monitor hormone levels or perform endometrial surveillance despite uncertainty about systemic absorption.
That's an argument against choosing it for this reason alone.
When therapy may fit
Hormone therapy for hair loss fits when a confirmed condition is doing measurable harm. Thyroid disease treated to normal function. PCOS managed for its metabolic and reproductive consequences, with androgen-driven hair changes improving as part of that. An endocrine disorder identified through the workup rather than assumed at the start.
Hormone therapy for hair loss also fits when hair is one line item in a longer list. If you're managing hot flashes and vaginal symptoms, and hair thinning is part of the picture, hormone therapy for hair loss becomes a reasonable component of a broader decision rather than the decision itself. Risks get weighed individually and the response gets monitored over months.
Set the timeline honestly. Even when a trigger resolves cleanly, hair grows back at a fraction of an inch per month, so you're measuring progress in seasons.
When shedding may worsen
Hormone therapy for hair loss can also move things in the wrong direction, and this deserves more airtime than it gets.
Testosterone exposure is the clearest case. A retrospective cohort study found that transmasculine patients receiving masculinizing gender-affirming hormone therapy had 2.5 times the rate of androgenetic alopecia compared with cisgender women. DermNet reports that androgenetic alopecia can appear within 12 months of commencing testosterone, with a mean onset of 3.25 years in one retrospective study and earlier onset for those with a family history.
The mechanism is the one from the pattern loss section. Androgen-sensitive follicles respond to what's circulating, and adding androgen accelerates a process that genetics already set up. This is a reason to discuss it before starting and to plan for it.
Abrupt changes cause their own trouble. Stopping oral contraceptives can trigger the same estrogen-withdrawal shedding seen postpartum, and any sharp dose change acts as a physiological stressor with the familiar two-to-three-month delay before the shedding appears. Temporary shedding after a dose adjustment of hormone therapy for hair loss is not the same as treatment failure, and telling them apart requires someone tracking the timeline with you.
When specialist care matters
Some findings shouldn't wait. Redness or a smooth shiny scalp where follicle openings have disappeared suggests an inflammatory or scarring process, and the window for preserving follicles closes. Sudden well-defined patches or hair loss that's accelerating week over week belong in dermatology quickly.
For everything else, the routing follows the suspicion. Primary care handles the initial history and the medication review. Dermatology owns scalp examination and the diagnosis of pattern versus scarring loss. Endocrinology takes over when thyroid or androgen abnormalities need interpretation beyond a single test result from hormone testing for hair loss. Gynecology fits when the picture centers on PCOS or the menopause transition.
Overlap between causes is normal, which is why the referral sequence matters more than picking the single right specialty first.
Book a TNT assessment
Sorting out whether hormones and hair loss are connected starts with the history. TNT Wellness has worked in functional health and hormone care since 1993. They review symptoms and medical history before deciding what testing is worth running. Their providers offer hormone testing and bioidentical hormone replacement therapy through virtual or in-person visits across the Charlotte area, including hormone therapy for hair loss. Book a consultation to talk through your timeline and what hormone therapy for hair loss would realistically involve. A dermatology referral is the right next step.